Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
Clinical trial NCT01059617 · COMPLETED
Trial details
- NCT number
- NCT01059617
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-09
- Primary completion
- 2011-01-14
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.